Eintrag weiter verarbeiten
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer.
Gespeichert in:
Zeitschriftentitel: | Journal of Clinical Oncology |
---|---|
Personen und Körperschaften: | , , , , , , , |
In: | Journal of Clinical Oncology, 32, 2014, 15_suppl, S. e16060-e16060 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
Schlagwörter: |
author_facet |
Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay |
---|---|
author |
Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay |
spellingShingle |
Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay Journal of Clinical Oncology A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. Cancer Research Oncology |
author_sort |
aggarwal, rahul raj |
spelling |
Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. Journal of Clinical Oncology |
doi_str_mv |
10.1200/jco.2014.32.15_suppl.e16060 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
American Society of Clinical Oncology (ASCO), 2014 |
imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2014 |
issn |
0732-183X 1527-7755 |
issn_str_mv |
0732-183X 1527-7755 |
language |
English |
mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
match_str |
aggarwal2014amulticenterphaseistudyofcabazitaxelmitoxantroneandprednisoneforchemotherapynaivepatientswithmetastaticcastrationresistantprostatecancer |
publishDateSort |
2014 |
publisher |
American Society of Clinical Oncology (ASCO) |
recordtype |
ai |
record_format |
ai |
series |
Journal of Clinical Oncology |
source_id |
49 |
title |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_unstemmed |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_full |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_fullStr |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_full_unstemmed |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_short |
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_sort |
a multicenter phase i study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
topic |
Cancer Research Oncology |
url |
http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 |
publishDate |
2014 |
physical |
e16060-e16060 |
description |
|
container_issue |
15_suppl |
container_start_page |
0 |
container_title |
Journal of Clinical Oncology |
container_volume |
32 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792324866447245331 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T11:56:29.804Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+multicenter+phase+I+study+of+cabazitaxel%2C+mitoxantrone%2C+and+prednisone+for+chemotherapy-naive+patients+with+metastatic+castration-resistant+prostate+cancer.&rft.date=2014-05-20&genre=article&issn=1527-7755&volume=32&issue=15_suppl&pages=e16060-e16060&jtitle=Journal+of+Clinical+Oncology&atitle=A+multicenter+phase+I+study+of+cabazitaxel%2C+mitoxantrone%2C+and+prednisone+for+chemotherapy-naive+patients+with+metastatic+castration-resistant+prostate+cancer.&aulast=Small&aufirst=Eric+Jay&rft_id=info%3Adoi%2F10.1200%2Fjco.2014.32.15_suppl.e16060&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792324866447245331 |
author | Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay |
author_facet | Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay, Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay |
author_sort | aggarwal, rahul raj |
container_issue | 15_suppl |
container_start_page | 0 |
container_title | Journal of Clinical Oncology |
container_volume | 32 |
description | |
doi_str_mv | 10.1200/jco.2014.32.15_suppl.e16060 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNC4zMi4xNV9zdXBwbC5lMTYwNjA |
imprint | American Society of Clinical Oncology (ASCO), 2014 |
imprint_str_mv | American Society of Clinical Oncology (ASCO), 2014 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0732-183X, 1527-7755 |
issn_str_mv | 0732-183X, 1527-7755 |
language | English |
last_indexed | 2024-03-01T11:56:29.804Z |
match_str | aggarwal2014amulticenterphaseistudyofcabazitaxelmitoxantroneandprednisoneforchemotherapynaivepatientswithmetastaticcastrationresistantprostatecancer |
mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
physical | e16060-e16060 |
publishDate | 2014 |
publishDateSort | 2014 |
publisher | American Society of Clinical Oncology (ASCO) |
record_format | ai |
recordtype | ai |
series | Journal of Clinical Oncology |
source_id | 49 |
spelling | Aggarwal, Rahul Raj Weinberg, Vivian K. Ryan, Charles J. Harzstark, Andrea Lynne Bryce, Alan Haruo Derleth, Christina Louise Lowe, Kimberly Small, Eric Jay 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. Journal of Clinical Oncology |
spellingShingle | Aggarwal, Rahul Raj, Weinberg, Vivian K., Ryan, Charles J., Harzstark, Andrea Lynne, Bryce, Alan Haruo, Derleth, Christina Louise, Lowe, Kimberly, Small, Eric Jay, Journal of Clinical Oncology, A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer., Cancer Research, Oncology |
title | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_full | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_fullStr | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_full_unstemmed | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_short | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_sort | a multicenter phase i study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
title_unstemmed | A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer. |
topic | Cancer Research, Oncology |
url | http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e16060 |